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Gouty arthritis is a chronic disease, characterized by 
hyperuricemia, precipitating the deposition of inﬂ  amma-
tory monosodium urate (MSU) crystals in various tissues. 
Phagocytic uptake by monocytes and granulocytes of 
these crystals causes tissue inﬂ  ammation such as syno-
vitis and often results in bone destruction. Under physio-
logical conditions, the integrity of bone is maintained by 
the balanced activity of osteoclasts and osteoblasts, 
which are responsible for bone resorption and bone 
formation, respectively. Th  e  diﬀ  erentiation of monocytes 
into osteoclasts depends on the presence of the receptor 
activator of NF-κB ligand (RANKL) and is antagonized 
by osteoprotegerin. In chronic inﬂ  ammatory  diseases, 
such as arthritis, a preponderance of RANKL leads to 
bone loss by enhanced osteoclastogenesis. In the case of 
gout there has been evidence for an association between 
the occurrence of gouty tophi and bone destruction. Yet 
so far the mechanisms are still elusive.
In samples of gouty tissue Lee and colleagues observed 
osteolytic lesions close to the tophi [1]. Stromal tissue 
was inﬁ  ltrated with inﬂ  ammatory T cells, B cells, and 
mast cells, whereas the tophi themselves were surrounded 
by tartrate-resistant acid phosphatase-positive multi-
nucleated osteoclasts. Th  e occurrence of the latter may 
be explained by the presence of the pro-resorptive 
cytokines IL-1β, IL-6, and TNFα in the inﬁ  ltrated stromal 
tissue. Th  ese cytokines reportedly enhance generation 
and activation of osteoclasts directly or indirectly via the 
induction of RANKL [2]. Analyzing CD3-expressing 
cells, the authors further claim a key role for T cells in 
bone destruction, since activated T cells in the tissue 
upregulate the expression of RANKL, considered the 
master regulator of osteoclastogenesis.
Twelve years ago Kong and colleagues ﬁ  rst reported 
that activated T cells promote osteoclastogenesis by the 
expression of RANKL [3]. Meanwhile several groups 
investigated the relationship between T cells and osteo-
clasts. In many osteolytic conditions (for example, rheu-
ma  toid arthritis or periodontal disease), RANKL-
expressing T cells are located at the sites of increased 
bone resorption [4]. Lee and colleagues added gouty 
arthritis to this list [1]. Interestingly, we recently reported 
that, in contrast to eﬀ  ector T cells, regulatory T cells 
suppress osteo  clasto  genesis [5]. In this context, the exact 
subpopu  lation(s) of T cells and the pathways responsible 
for the expression of RANKL within the inﬂ  amed gouty 
tissue are of major interest.
Lee and colleagues and others reported that MSU 
crystals induce the expression and the release of the pro-
resorptive cytokines IL-1α, IL-1β, IL-6, and TNFα in 
monocytes in a dose-dependent manner [6,7]. Th  e up-
regulation and downregulation of RANKL and osteo-
protegerin by MSU-stimulated T cells was observed 
24 hours and, even stronger, 72 hours after co-incubation, 
respectively. Th  e authors employed negatively selected 
highly enriched T cells (>95%) for their experiments, and 
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© 2011 BioMed Central Ltdtherefore claim a direct eﬀ  ect on the T cells of MSU 
crystals. However, there are other options as well: 
negatively selected T cells often contain huge numbers of 
platelets, which are not addressed by the depleting 
antibody cocktail; and minor contaminations with other 
leukocytes may inﬂ  uence the outcome.
Nevertheless, the expression of RANKL by T cells after 
stimulation with MSU is a new and interesting ﬁ  nding 
and has not yet been described. Th   e authors’ hypothesis 
of T cells promoting osteoclasts is strengthened by in 
vitro assays employing peripheral blood mononuclear 
cells or synovial ﬂ   uid mononuclear cells (SFMCs) of 
patients suﬀ   ering from gout. After stimulation with 
RANKL, SFMCs formed more osteoclasts than the 
peripheral blood mononuclear cells. Th  is is consistent 
with the data of Dalbeth and colleagues [8]. Lee and 
colleagues further showed that T-cell depletion from 
SFMCs almost abrogated osteoclastogenesis. Th  is  ﬁ  nding 
is consistent with the hypothesis that T cells are a main 
source of RANKL under inﬂ   ammatory conditions. A 
recent publication, however, reported that B cells out-
range T cells in the transcription of mRNA for RANKL in 
patients with RA [9]. In this regard, it would be 
interesting to perform osteoclast assays with B-cell-
depleted SFMCs.
In summary, bone destruction in gouty arthritis seems 
to be the result of an imbalance in bone remodeling. Th  e 
overexpression of RANKL, presumably by inﬁ  ltrating 
T  cells in a proinﬂ   ammatory environment, promotes 
osteo  clastogenesis. Concomitantly, the RANKL antagonist 
osteoprotegerin is downregulated. Tophus-associated 
mono  cytes contribute IL-1β, IL-6, and TNFα, which act 
as additional promoters for osteoclast diﬀ  erentiation.
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